Dividends Inside 
Pulsenmore Ltd.
PLSM
$4.00 (- $0.47 - 10.49%)
Last updated: 2026-05-20 22:43 UTC
Pulsenmore Ltd. trades under ticker PLSM on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN IL0011767006.
About the Company
Pulsenmore Ltd. is a healthcare technology company that develops and markets home-use ultrasound and digital health solutions focused primarily on prenatal care. The company’s core offering is a self-scan ultrasound system that combines a handheld ultrasound cradle that docks with a patient’s smartphone, a dedicated mobile application, and secure cloud infrastructure for image transmission and storage. This setup enables pregnant women to perform guided scans at home, with images and video made available for physician-supervised review and remote clinical assessment. Pulsenmore Ltd. serves the broader telehealth, digital health, and femtech segments by supporting remote monitoring, reducing dependence on in-clinic visits, and integrating with clinician dashboards and workflows. Headquartered in Israel, the company positions its technology as an infrastructure component for healthcare providers and payers seeking to expand remote prenatal services and improve continuity of care within existing medical systems.
Price History
Latest News for PLSM
Pulsenmore Announces Full Year 2025 Earnings Conference Call
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30, 2026 at 8:30 a.m. EST.
Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine and women's ultrasound practice in Maryland, as part of its growing U.S. rollout.
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the United States, following receipt of FDA approval for its home pregnancy ultrasound product.
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced an additional strategic commercial agreement with Clalit Health Services, Israel's largest health maintenance organization (HMO), to supply Pulsenmore FC, a new at-home ultrasound solution designed for remote follicular monitoring in women undergoing fertility care (IVF and fertility preservation). The agreement is potentially valued at approximately $ 4.5 million over five years
Pulsenmore to commence trading on Nasdaq
Pulsenmore (PLSM)announced that its shares will begin trading on Nasdaq at the U.S. market open on January 21. The company’s shares will trade under the ticker symbol “PLSM” on the Nasdaq Capital Market as well as the Tel Aviv Stock Exchange. Pulsenmore is a digital health company developing home-use ultrasound and telehealth technology that enables physician-supervised prenatal monitoring outside traditional clinical settings. Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and power
Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report
US stocks look set to open higher in Thursday's trading session as investors parse gross domestic pr